Stocks
Novan IncNOVN
HealthcareBiotechnology
A clinical-stage biopharmaceutical company developing novel therapies for inflammatory and autoimmune diseases. Its lead candidates target validated pathways with potential for improved efficacy and safety profiles. Investors track Novan for its pipeline progress and partnership potential in the immunology space.
Congressional Interest in Novan Inc (NOVN)
2 members of Congress have disclosed 2 trades in Novan Inc (NOVN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
1
Sells
1
Who in Congress Is Trading NOVN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-08-06 | Sheldon Whitehouse | sell | $1K-$15K |
| 2020-01-06 | David P. Roe | buy | $1K-$15K |